JCI - Therapeutic hypoxia for mitochondrial disease via enhancement of hemoglobin affinity and inhibition of HIF-2α

Go to JCI Insight

About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact

Clinical Research and Public Health
Current issue
Past issues
By specialty
Videos
- Conversations with Giants in Medicine
- Video Abstracts
Reviews
Viewpoint
Collections

The Journal of Clinical Investigation
Current issue
Past issues
Specialties
Reviews
Review series
Videos
Conversations with Giants in Medicine
Video Abstracts
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Reviews
Viewpoints
100th anniversary
Top read articles
Journal Details
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact

Therapeutic hypoxia for mitochondrial disease via enhancement of hemoglobin affinity and inhibition of HIF-2α

Hong Wang, … , Fumito Ichinose, Vamsi K. Mootha

Hong Wang, … , Fumito Ichinose, Vamsi K. Mootha

Published December 2, 2024
Citation Information: J Clin Invest. 2024;134(23):e185569. https://doi.org/10.1172/JCI185569.

View: Text | PDF

Research Letter Genetics

Therapeutic hypoxia for mitochondrial disease via enhancement of hemoglobin affinity and inhibition of HIF-2α

Text
PDF

Abstract

Authors

Hong Wang, Maria Miranda, Eizo Marutani, Paul Lichtenegger, Gregory R. Wojtkiewicz, Fumito Ichinose, Vamsi K. Mootha

×

Full Text PDF | Download (763.12 KB)

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts